NCP chief Sharad Pawar takes first dose of COVID-19 vaccine
PTI, Mar 1, 2021, 4:20 PM IST
Source: Wikipedia
Mumbai: NCP chief Sharad Pawar, his wife, and MP daughter on Monday received the first dose of COVID-19 vaccine at a civic hospital here in Maharashtra, a senior health official said.
The former Union minister was administered the ‘Covishield’ vaccine, which is manufactured by the Pune-based Serum Institute of India (SII) in collaboration with the University of Oxford and AstraZeneca, he said.
”Pawar (80) took the first shot of the vaccine along with his wife Pratibha Pawar and daughter Supriya Sule,” Dr. Tatyaro Lahane, Director of the Directorate of Medical Education and Research (DMER), told reporters.
Sule (51) represents the Baramati Lok Sabha seat in the Pune district.
On Monday, the second phase of the COVID-19 vaccination drive began nationwide wherein people above 60 years of age and those over 45 years with comorbidities will be able to get the COVID-19 vaccine for free at government facilities and for a charge at many private hospitals.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Jayant Patil claims BJP used irrigation ‘scam’ to blackmail Ajit Pawar; Fadnavis, NCP chief hit back
Medical College expels 5 MBBS students from hostel for ragging juniors
Insulting women is in DNA of Cong leaders, alleges Jharkhand BJP
Man arrested from Delhi for calling up Pappu Yadav posing as aide of Lawrence Bishnoi
Shah Rukh Khan turns 59, fans wait outside Mannat to catch superstar’s glimpse
MUST WATCH
Latest Additions
Jayant Patil claims BJP used irrigation ‘scam’ to blackmail Ajit Pawar; Fadnavis, NCP chief hit back
Medical College expels 5 MBBS students from hostel for ragging juniors
Insulting women is in DNA of Cong leaders, alleges Jharkhand BJP
Man arrested from Delhi for calling up Pappu Yadav posing as aide of Lawrence Bishnoi
Tejasvi Surya hits out at Kharge, CMs of Cong-ruled states over poll promises
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.